Swiss National Bank’s NewAmsterdam Pharma NAMS Stock Holding History

Swiss National Bank’s Portfolio NAMS Stock Details NAMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.1M	Buy	121,100 +32,200	+36%	+$1.06M	﹤0.01%	1556
2026 Q1	$2.85M	Hold	88,900	–	–	﹤0.01%	1669
2025 Q4	$3.12M	Buy	88,900 +1,800	+2%	+$65.5K	﹤0.01%	1631
2025 Q3	$2.48M	Buy	87,100 +3,200	+4%	+$76.7K	﹤0.01%	1744
2025 Q2	$1.52M	Buy	83,900 +13,000	+18%	+$237K	﹤0.01%	1943
2025 Q1	$1.45M	Sell	70,900 -1,100	-2%	-$24.5K	﹤0.01%	1948
2024 Q4	$1.85M	Buy	72,000 +36,900	+105%	+$784K	﹤0.01%	1900
2024 Q3	$583K	Hold	35,100	–	–	﹤0.01%	2400
2024 Q2	$674K	Buy	+35,100	New	+$704K	﹤0.01%	2340

Other funds holding NAMS

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Swiss National Bank's NAMS Position: Q2 2026 in Review

Swiss National Bank increased its NewAmsterdam Pharma (NAMS) stake by 36% in Q2 2026, buying an estimated $1.06M and bringing the position to 121,100 shares worth $4.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1556.

Swiss National Bank first reported a position in NAMS in Q2 2024 and has held it in 9 quarters since. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

Swiss National Bank held 121,100 shares of NewAmsterdam Pharma worth $4.1M as of Q2 2026.
Swiss National Bank bought 32,200 NewAmsterdam Pharma shares in Q2 2026, an estimated $1.06M.
NewAmsterdam Pharma made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1556 holding.
Swiss National Bank first reported a position in NewAmsterdam Pharma in Q2 2024 and has held it in 9 quarters since.
194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.